Abstract
It is important to secure visibility during microsurgery. In vitreous surgery, staining and peeling of the internal limiting membrane with vital dyes, such as indocyanine green, have been widely performed since 2000, and surgical outcomes have improved in some vitreoretinal disorders such as macular holes and epiretinal membranes. It has been subsequently shown that triamcinolone acetonide is an adjuvant that is extremely effective for intraoperative vitreous visualization. In recent years, the term 'chromovitrectomy' has been used for performance of a vitrectomy using these surgical adjuvants for improved visibility. While there have been reports that an auxiliary chromovitrectomy with vital dyes is very effective, the question of retinal toxicity with use of these dyes remains. Therefore, a new safer vital dye, i.e. brilliant blue G, was developed and applied in clinical use. Chromovitrectomy using these adjuvants is an important technique that has low invasiveness and is very safe and very helpful in microincision vitrectomy surgery.
| Original language | English |
|---|---|
| Pages (from-to) | 120-125 |
| Number of pages | 6 |
| Journal | Developments in Ophthalmology |
| Volume | 54 |
| DOIs | |
| Publication status | Published - Jan 1 2014 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Ophthalmology
Cite this
Chromovitrectomy and vital dyes. / Enaida, Hiroshi; Hisatomi, Toshio; nakao, shintaro; Ikeda, Yasuhiro; Yoshida, Shigeo; Ishibashi, Tatsuro.
In: Developments in Ophthalmology, Vol. 54, 01.01.2014, p. 120-125.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Chromovitrectomy and vital dyes
AU - Enaida, Hiroshi
AU - Hisatomi, Toshio
AU - nakao, shintaro
AU - Ikeda, Yasuhiro
AU - Yoshida, Shigeo
AU - Ishibashi, Tatsuro
PY - 2014/1/1
Y1 - 2014/1/1
N2 - It is important to secure visibility during microsurgery. In vitreous surgery, staining and peeling of the internal limiting membrane with vital dyes, such as indocyanine green, have been widely performed since 2000, and surgical outcomes have improved in some vitreoretinal disorders such as macular holes and epiretinal membranes. It has been subsequently shown that triamcinolone acetonide is an adjuvant that is extremely effective for intraoperative vitreous visualization. In recent years, the term 'chromovitrectomy' has been used for performance of a vitrectomy using these surgical adjuvants for improved visibility. While there have been reports that an auxiliary chromovitrectomy with vital dyes is very effective, the question of retinal toxicity with use of these dyes remains. Therefore, a new safer vital dye, i.e. brilliant blue G, was developed and applied in clinical use. Chromovitrectomy using these adjuvants is an important technique that has low invasiveness and is very safe and very helpful in microincision vitrectomy surgery.
AB - It is important to secure visibility during microsurgery. In vitreous surgery, staining and peeling of the internal limiting membrane with vital dyes, such as indocyanine green, have been widely performed since 2000, and surgical outcomes have improved in some vitreoretinal disorders such as macular holes and epiretinal membranes. It has been subsequently shown that triamcinolone acetonide is an adjuvant that is extremely effective for intraoperative vitreous visualization. In recent years, the term 'chromovitrectomy' has been used for performance of a vitrectomy using these surgical adjuvants for improved visibility. While there have been reports that an auxiliary chromovitrectomy with vital dyes is very effective, the question of retinal toxicity with use of these dyes remains. Therefore, a new safer vital dye, i.e. brilliant blue G, was developed and applied in clinical use. Chromovitrectomy using these adjuvants is an important technique that has low invasiveness and is very safe and very helpful in microincision vitrectomy surgery.
UR - http://www.scopus.com/inward/record.url?scp=84929518789&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929518789&partnerID=8YFLogxK
U2 - 10.1159/000360457
DO - 10.1159/000360457
M3 - Article
C2 - 25196760
AN - SCOPUS:84929518789
VL - 54
SP - 120
EP - 125
JO - Developments in Ophthalmology
JF - Developments in Ophthalmology
SN - 0250-3751
ER -